{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:13:41Z","timestamp":1792253621346,"version":"4.4.0"},"reference-count":34,"publisher":"University of Tokushima Faculty of Medicine","issue":"3.4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2023]]},"DOI":"10.2152\/jmi.70.450","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T22:15:00Z","timestamp":1699481700000},"page":"450-456","source":"Crossref","is-referenced-by-count":5,"title":["Lipoprotein (a) is a risk factor of aortic valve calcification in patients with a risk of atherosclerosis"],"prefix":"10.2152","volume":"70","author":[{"given":"Munkhtsetseg","family":"Tserensonom","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"},{"name":"Department of Community Medicine and Human Resource Development, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ise","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kawabata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneyuki","family":"Kadota","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Kusunos","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Soeki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuzo","family":"Wakatsuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Sata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Vavilis G, B?ck M, B?r?ny P, Szummer K:Epidemiology of Aortic Stenosis\/Aortic Valve Replacement (from the Nationwide Swedish Renal Registry). Am J Cardiol 163:58-64, 2022","DOI":"10.1016\/j.amjcard.2021.09.046"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Peeters FECM, Meex SJR, Dweck MR, Aikawa E, Crijns HJGM, Schurgers LJ, Kietselaer BLJH:Calcific aortic valve stenosis:hard disease in the heart. Eur Heart J 39:2618-2624, 2018","DOI":"10.1093\/eurheartj\/ehx653"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM:Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 29:630-634, 1997","DOI":"10.1016\/S0735-1097(96)00563-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Owens DS, Katz R, Takasu J, Kronmal R, Budoff MJ, O\u2019Brien KD:Incidence and Progression of Aortic Valve Calcium in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Cardiol 105:701-708, 2010","DOI":"10.1016\/j.amjcard.2009.10.071"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Goody PR, Hosen MR, Christmann D, Niepmann ST, Zietzer A, Adam M, B?nner F, Zimmer S, Nickenig G, Jansen F:Aortic valve stenosis:From basic mechanisms to novel therapeutic targets. Arterioscler Thromb Vasc Biol :?885-900, 2020?","DOI":"10.1161\/ATVBAHA.119.313067"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mohty D, Pibarot P, Despr?s J-P, C?t? C, Arsenault B, Cartier A, Cosnay P, Couture C, Mathieu P:Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic Stenosis. Arterioscler Thromb Vasc Biol 28:187-193, 2008","DOI":"10.1161\/ATVBAHA.107.154989"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kaiser Y, Singh SS, Zheng KH, Verbeek R, Kavousi M, Pinto S-J, Vernooij MW, Sijbrands EJG, Matthijs Boekholdt S, De Rijke YB, Stroes ESG, Bos D:Lipoprotein(a) is robustly associated with aortic valve calcium Valvular heart disease. Heart 0:1-7, 2021","DOI":"10.1093\/ehjci\/ehaa946.1873"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Artiach G, Carracedo M, Plunde O, Wheelock CE, Thul S, Sj?vall P, Franco-Cereceda A, Laguna-Fernandez A, Arnardottir H, B?ck M:Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease Through the Resolvin E1 and ChemR23 Axis. Circulation 142:776-789, 2020","DOI":"10.1161\/CIRCULATIONAHA.119.041868"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Cueff C, Serfaty J-M, Cimadevilla C, Laissy J-P, Himbert D, Tubach F, Duval X, Iung B, Enriquez-Sarano M, Vahanian A, Messika-Zeitoun D:Measurement of aortic valve calcification using multislice computed tomography:correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart 97:721-726, 2011","DOI":"10.1136\/hrt.2010.198853"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hokken TW, Ooms JF, Kardys I, Hirsch A, Weustink AC, Schipper S, Heil P, Daemen J, Budde RPJ, Van Mieghem NM:Validation of a Three-Dimensional Computed Tomography Reconstruction Tool for Aortic Valve Calcium Quantification. Struct Hear:100122, 2022","DOI":"10.1016\/j.shj.2022.100122"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Toyofuku M, Taniguchi T, Morimoto T, Yamaji K, Furukawa Y, Takahashi K, Tamura T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Murakami T, Takeuchi Y, Yamane K, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T:Sex Differences in Severe Aortic Stenosis \u2212 Clinical Presentation and Mortality \u2212. Circ J 81:1213-1221, 2017","DOI":"10.1253\/circj.CJ-16-1244"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Venardos N, Gergen AK, Jarrett M, Weyant MJ, Reece TB, Meng X, Fullerton DA:Warfarin Induces Calcification of the Aortic Valve Through Extracellular Signal-regulated Kinase 1\/2 and ?-catenin Signaling. Ann Thorac Surg 113:824-835, 2022","DOI":"10.1016\/j.athoracsur.2021.03.099"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Delaney JA, Lehmann N, J?ckel K-H, Elmariah S, Psaty BM, Mahabadi AA, Budoff M, Kronmal RA, Nasir K, O\u2019Brien KD, M?hlenkamp S, Moebus S, Dragano N, Winterstein AG, Erbel R, K?lsch H:Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification:The Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Atherosclerosis 229:310-316, 2013","DOI":"10.1016\/j.atherosclerosis.2013.05.002"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, Lloyd-Jones DM, Marcovina SM, Yeang C, Koschinsky ML:Lipoprotein(a):A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease:A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol 42(1):e48-e60, 2022?","DOI":"10.1161\/ATV.0000000000000147"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith A V., Peloso GM, Kerr KF, Pechlivanis S, Budoff MJ, Harris TB, Malhotra R, O\u2019Brien KD, Kamstrup PR, Nordestgaard BG, Tybjaerg-Hansen A, Allison MA, Aspelund T, Criqui MH, Heckbert SR, Hwang S-J, Liu Y, Sjogren M, van der Pals J, K?lsch H, M?hleisen TW, N?then MM, Cupples LA, Caslake M, Di Angelantonio E, Danesh J, Rotter JI, Sigurdsson S, Wong Q, Erbel R, Kathiresan S, Melander O, Gudnason V, O\u2019Donnell CJ, Post WS:Genetic Associations with Valvular Calcification and Aortic Stenosis. N Engl J Med 368:503-512, 2013","DOI":"10.1056\/NEJMoa1109034"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Capoulade R, Chan KL, Yeang C, Mathieu P, Boss? Y, Dumesnil JG, Tam JW, Teo KK, Mahmut A, Yang X, Witztum JL, Arsenault BJ, Despr?s J-P, Pibarot P, Tsimikas S:Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis. J Am Coll Cardiol 66:1236-1246, 2015","DOI":"10.1016\/j.jacc.2015.07.020"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Goody PR, Hosen MR, Christmann D, Niepmann ST, Zietzer A, Adam M, B?nner F, Zimmer S, Nickenig G, Jansen F:Aortic Valve Stenosis. Arterioscler Thromb Vasc Biol 40:885-900, 2020","DOI":"10.1161\/ATVBAHA.119.313067"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tsimikas S:A test in context:Lipoprotein(a):Diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol 69:692-711, 2017","DOI":"10.1016\/j.jacc.2016.11.042"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hughes SD, Lou XJ, Ighani S, Verstuyft J, Grainger DJ, Lawn RM, Rubin EM:Lipoprotein(a) vascular accumulation in mice:In vivo analysis of the role of lysine binding sites using recombinant adenovirus. J Clin Invest 100:1493-1500, 1997","DOI":"10.1172\/JCI119671"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yu B, Khan K, Hamid Q, Mardini A, Siddique A, Aguilar-Gonzalez LP, Makhoul G, Alaws H, Genest J, Thanassoulis G, Cecere R, Schwertani A:Pathological significance of lipoprotein(a) in aortic valve stenosis. Atherosclerosis 272:168-174, 2018","DOI":"10.1016\/j.atherosclerosis.2018.03.025"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Schnitzler JG, Ali L, Groenen AG, Kaiser Y, Kroon J:Lipoprotein(A) as orchestrator of calcific aortic valve stenosis. Biomolecules 9:2019","DOI":"10.3390\/biom9120760"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yuan S, B?ck M, Bruzelius M, Mason AM, Burgess S, Larsson S:Plasma Phospholipid Fatty Acids, FADS1 and Risk of 15 Cardiovascular Diseases:A Mendelian Randomisation Study. Nutrients 11:3001, 2019","DOI":"10.3390\/nu11123001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Chen HY, Cairns BJ, Small AM, Burr HA, Ambikkumar A, Martinsson A, Th?riault S, Munter HM, Steffen B, Zhang R, Levinson RT, Shaffer CM, Rong J, Sonestedt E, Dufresne L, Ljungberg J, N?slund U, Johansson B, Ranatunga DK, Whitmer RA, Budoff MJ, Nguyen A, Vasan RS, Larson MG, Harris WS, Damrauer SM, Stark KD, Boekholdt SM, Wareham NJ, Pibarot P, Arsenault BJ, Mathieu P, Gudnason V, O\u2019Donnell CJ, Rotter JI, Tsai MY, Post WS, Clarke R, S?derberg S, Boss? Y, Wells QS, Smith JG, Rader DJ, Lathrop M, Engert JC, Thanassoulis G:Association of FADS1\/2 Locus Variants and Polyunsaturated Fatty Acids With Aortic Stenosis. JAMA Cardiol 5:694, 2020","DOI":"10.1001\/jamacardio.2020.0246"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. O\u2019Brien KD:Pathogenesis of Calcific Aortic Valve Disease. Arterioscler Thromb Vasc Biol 26:1721-1728, 2006","DOI":"10.1161\/01.ATV.0000227513.13697.ac"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Olsson M, Thyberg J, Nilsson J:Presence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves. Arterioscler Thromb Vasc Biol 19:1218-1222, 1999","DOI":"10.1161\/01.ATV.19.5.1218"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, Moriarty PM, Rader DJ, Remaley AT, Reyes-Soffer G, Santos RD, Thanassoulis G, Witztum JL, Danthi S, Olive M, Liu L:NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis. J Am Coll Cardiol 71:177-192, 2018","DOI":"10.1016\/j.jacc.2017.11.014"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Afshar M, Kamstrup PR, Williams K, Sniderman AD, Nordestgaard BG, Thanassoulis G:Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis\u2014Brief Report. Arterioscler Thromb Vasc Biol 36:2421-2423, 2016","DOI":"10.1161\/ATVBAHA.116.308271"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, Boon NA:A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis. N Engl J Med 352:2389-2397, 2005","DOI":"10.1056\/NEJMoa043876"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR:Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med 376:1713-1722, 2017","DOI":"10.1056\/NEJMoa1615664"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJP:Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events. N Engl J Med 372:1489-1499, 2015","DOI":"10.1056\/NEJMoa1501031"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ekelund U, Tarp J, Steene-Johannessen J, Hansen BH, Jefferis B, Fagerland MW, Whincup P, Diaz KM, Hooker SP, Chernofsky A, Larson MG, Spartano N, Vasan RS, Dohrn I-M, Hagstr?mer M, Edwardson C, Yates T, Shiroma E, Anderssen SA, Lee I-M:Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality:systematic review and harmonised meta-analysis. BMJ 366:l4570, 2019","DOI":"10.1136\/bmj.l4570"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Julius U:Niacin as antidyslipidemic drug. Can J Physiol Pharmacol 93:1043-1054, 2015","DOI":"10.1139\/cjpp-2014-0478"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ray KK, Wright RS, Kallend D, Koenig W, Leiter LA, Raal FJ, Bisch JA, Richardson T, Jaros M, Wijngaard PLJ, Kastelein JJP:Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol. N Engl J Med 382:1507-1519, 2020","DOI":"10.1056\/NEJMoa1912387"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Tsimikas S, Karwatowska-Prokopczuk E, Gouni-Berthold I, Tardif J-C, Baum SJ, Steinhagen-Thiessen E, Shapiro MD, Stroes ES, Moriarty PM, Nordestgaard BG, Xia S, Guerriero J, Viney NJ, O\u2019Dea L, Witztum JL:Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. N Engl J Med 382:244-255, 2020","DOI":"10.1056\/NEJMoa1905239"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/70\/3.4\/70_450\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:22:47Z","timestamp":1715577767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/70\/3.4\/70_450\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":34,"journal-issue":{"issue":"3.4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.70.450","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]}}}